Key result
Microinjection of A-kinase or elevation of cAMP in fibroblasts caused a transient, reversible loss of actin microfilament bundles, likely via phosphorylation and inhibition of MLCK.
Why the study?
Does A-kinase regulate microfilament integrity through phosphorylation and inhibition of MLCK activity in nonmuscle cells?
Does A-kinase regulate microfilament integrity through phosphorylation and inhibition of MLCK activity in nonmuscle cells?
A-kinase regulates microfilament integrity in nonmuscle cells by phosphorylating and inhibiting MLCK activity.
These in vitro findings are hypothesis-generating for cAMP-MLCK cytoskeletal control; relevance to cardiovascular cells or disease remains untested.
Microinjection of the catalytic subunit of cAMP-dependent protein kinase (A-kinase) into living fibroblasts or the treatment of these cells with agents that elevate the intracellular cAMP level caused marked alterations in cell morphology including a rounded phenotype and a complete loss of actin microfilament bundles. These effects were transient and fully reversible. Two-dimensional gel electrophoresis was used to analyze the changes in phosphoproteins from cells injected with A-kinase. These experiments showed that accompanying the disassembly of actin microfilaments, phosphorylation of myosin light chain kinase (MLCK) increased and concomitantly, the phosphorylation of myosin P-light chain decreased. Moreover, inhibiting MLCK activity via microinjection of affinity-purified antibodies specific to native MLCK caused a complete loss of microfilament bundle integrity and a decrease in myosin P-light chain phosphorylation, similar to that seen after injection of A-kinase. These data support the idea that A-kinase may regulate microfilament integrity through the phosphorylation and inhibition of MLCK activity in nonmuscle cells.
No takes yet. Share an insight, caveat, or question.
Lamb et al. (1988) studied Living nonmuscle cells (fibroblasts). Microinjection of cAMP-dependent protein kinase (A-kinase) or cAMP-elevating agents was evaluated on Cell morphology and actin microfilament bundle integrity. Microinjection of A-kinase or elevation of cAMP in fibroblasts caused a transient, reversible loss of actin microfilament bundles, likely via phosphorylation and inhibition of MLCK.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: